GB0508924D0 - New use - Google Patents

New use

Info

Publication number
GB0508924D0
GB0508924D0 GBGB0508924.8A GB0508924A GB0508924D0 GB 0508924 D0 GB0508924 D0 GB 0508924D0 GB 0508924 A GB0508924 A GB 0508924A GB 0508924 D0 GB0508924 D0 GB 0508924D0
Authority
GB
United Kingdom
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0508924.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0508924.8A priority Critical patent/GB0508924D0/en
Publication of GB0508924D0 publication Critical patent/GB0508924D0/en
Priority to PCT/GB2006/001582 priority patent/WO2006117534A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
GBGB0508924.8A 2005-04-30 2005-04-30 New use Ceased GB0508924D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0508924.8A GB0508924D0 (en) 2005-04-30 2005-04-30 New use
PCT/GB2006/001582 WO2006117534A2 (en) 2005-04-30 2006-04-28 New use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0508924.8A GB0508924D0 (en) 2005-04-30 2005-04-30 New use

Publications (1)

Publication Number Publication Date
GB0508924D0 true GB0508924D0 (en) 2005-06-08

Family

ID=34674198

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0508924.8A Ceased GB0508924D0 (en) 2005-04-30 2005-04-30 New use

Country Status (2)

Country Link
GB (1) GB0508924D0 (en)
WO (1) WO2006117534A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA032476B1 (en) 2006-07-05 2019-06-28 Астразенека Аб PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION THEREOF AND MEDICAMENT COMPRISING HMG-CoA REDUCTASE AND PHOSPHODIESTERASE 4 INHIBITORS, USE THEREOF FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
US6576256B2 (en) * 2001-08-28 2003-06-10 The Brigham And Women's Hospital, Inc. Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
WO2003050261A2 (en) * 2001-12-10 2003-06-19 Bristol-Myers Squibb Company (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
WO2004014923A1 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc Pyrimidinone fused bicyclic metalloproteinase inhibitors
US7517900B2 (en) * 2003-10-10 2009-04-14 Bristol-Myers Squibb Company Pyrazole derivatives as cannabinoid receptor modulators

Also Published As

Publication number Publication date
WO2006117534A2 (en) 2006-11-09
WO2006117534A3 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
GB0522715D0 (en) New use
GB0505954D0 (en) Novel use
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0506001D0 (en) Novel use
GB0526552D0 (en) New use
GB0502250D0 (en) Use
GB0506800D0 (en) New uses
GB0526032D0 (en) Use
GB0526031D0 (en) Use
EP1846443A4 (en) Novel use
GB0508924D0 (en) New use
GB0515817D0 (en) New use
GB0503949D0 (en) Use
GB0507986D0 (en) Use
GB0507874D0 (en) Use
GB0503950D0 (en) Use
GB0516653D0 (en) Novel use
GB0521273D0 (en) Novel use
GB0506015D0 (en) Novel use
GB0510589D0 (en) Novel use
GB0510591D0 (en) Novel use
GB0510592D0 (en) Novel use
GB0516650D0 (en) Novel use
GB0505991D0 (en) Novel use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)